Image

Global Spinal Devices and Biologics Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Spinal Devices and Biologics Market, By Type (Fusion Devices, Non-fusion Devices), Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas and Fractures, Others), End User (Hospitals and Ambulatory Surgery Centers, Specialty Clinics, Others) – Industry Trends and Forecast to 2029.

Spinal Devices and Biologics Market

Spinal Devices and Biologics Market Analysis and Size

The increasing use of spinal devices and biologics among surgeons has increased the need for products that utilize this technology. As the population ages, the prevalence of degenerative devices and age-related spinal deformities is rising, and the demand for spinal devices is increasing. Vertebrate includes materials that can be used for bone fusion surgery, spinal cord injury, and degenerative disc disease. Ten years ago, the spine treatment market was 75% traditional metal rods and plates and 25% biological products.

Data Bridge Market Research analyses the spinal devices and biologics market growth in the forecast period 2022-2029. The expected CAGR of spinal devices and biologics market is tend to be around 9.80% in the above mentioned forecast period. The market value was valued at USD 2.64 billion in 2021 and is expected to reach USD 5.58 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Spinal Devices and Biologics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Fusion Devices, Non-fusion Devices), Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas and Fractures, Others), End User (Hospitals and Ambulatory Surgery Centers, Specialty Clinics, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Exactech, Inc., (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), Globus Medical (U.S.), Integra LifeSciences (U.S.), NuVasive, Inc., (U.S.), Stryker (U.S.), Orthofix US LLC (U.S.), Wright Medical Group N.V. (U.S.), Smith+Nephew (U.K.), ZAVATION (U.S.)

Market Opportunities

  • Improvement in 3D printed implants and augmented and virtual reality for minimally invasive surgeries
  • Rise in elderly population and associated comorbidities

Market Definition

Biological substances actively change the environment and cause changes through biological processes. Biopharmacy is becoming an increasingly important component for spinal fusion because of its potential impact, the use of bone replacement materials, and growing awareness of the ever-increasing aging population.

Spinal devices are widely used in spinal surgeries for treating complications such as deformities, disc degeneration, and fractures. They actively enhance bone formation and stimulate spinal fusion, unlike inactive metals that do not alter cell function or stimulate cell growth.

Spinal Devices and Biologics Market Dynamics

Drivers

  • Increasing demand for a number of spinal surgeries

The increase in spinal diseases has increased spinal surgeries, which in turn is expanding the increasing demand for spinal devices. The primary reason for spinal surgeries is for the treatment of degenerative disc disease and for birth deformities. The rising number of minimally invasive surgeries is fuelling the growth of spinal devices and biologics market in the forecast period.

  • Launch of new products for increasing adoption of spinal devices

Various technological advancements in the spinal devices industry aided in discovering several orthopaedic implants that will better treat patients suffering from spinal diseases. The primary manufacturers in this sector are focusing on minimally invasive solutions and customized implants which will further increase the market's growth. In addition to this, strategic collaborations between several manufacturers led to the discovery of innovative technologies and solutions for spinal surgeries.

Opportunities

  • Improvement in 3D printed implants and augmented and virtual reality for minimally invasive surgeries

The artificial intelligence sector is developing, which in return is creating a significant impact on the spinal devices and biologics market. The more involvement of 3D printed implants is helping in improving the surgeries.

  • Rise in the elderly population and associated comorbidities

The increasing elderly population and their associated comorbidities are mainly fuelling the market growth opportunities. The aging population having obesity coupled with the rising number of spine deformities are expected to fuel the expansion of the spinal devices and biologics industry. All these conditions tend to implement the minimally invasive surgeries that will serve in the growth of the market.

Restraints/Challenges

  • High prices and unbalanced compensation policies

High price issues and unbalanced compensation policies can slow companies' growth in this market. Companies doing business in this area need to explain science with their products to be a pioneer in revenue generation. To do this, you need the right professionals with knowledge of these spinal devices and biopharmacy. Companies need to understand the current needs of their customers and be able to incorporate the latest innovations into their products. It helps them increase their sales. Companies operating in this market need to understand the importance of campaigns to raise awareness of these devices worldwide.

  • Lack of patient awareness

Not all patients know the proper procedures and the consequences of the surgeries. Thus, a lack of patient awareness can lead to lesser adoption of these devices and which in turn can lower the market growth of the spinal devices and biologics market.

Market Developments

  • Spine Wave announced in March 2021 the stronghold 3D Titanium Interbody Device's launch and works on the Ticell 3D advanced surface technology. This newest innovation will help the company to flourish in terms of complementing its innovative products.
  • In March 2021, Osseus Fusion Systems announced its Aries-TC launch. It is a 3D printing transforaminal curved interbody fusion device. This new device is beneficial to skeletally strong patients with the degenerative device.

Global Spinal Devices and Biologics Market Scope

The spinal devices and biologics market is segmented on the basis of type, disease indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Fusion Devices
  • Cervical
  • Thoracolumbar
  • Interbody
  • Biologics
  • Non-fusion devices
  • Vertebral compression fracture devices
  • Artificial discs
  • Dynamic stabilization devices
  • Others
  • Disease Indication
  • Degenerative Disc Disease
  • Complex Deformity
  • Traumas and Fractures
  • Others

End User

  • Hospitals and Ambulatory Surgery Centers
  • Specialty Clinics
  • Others

Spinal Devices and Biologics Market Analysis/Insights

The spinal devices and biologics market is analyzed and market size insights and trends are provided by country, type, disease indication and end user as referenced above.

The major countries covered in the spinal devices and biologics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the spinal devices and biologics market due to the increasing number of cases of spinal disease. Also, the main factors contributing to the dominance of the spinal devices and biologics market are new product launches, strategic collaborations, increased research on biologics, and rising prevalence of spinal diseases.

Asia-Pacific is expected to grow from 2022 to 2029 due to rising income levels, rising health care costs, a large patient population, and increased government funding and awareness of these devices.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Spinal Devices and Biologics Market Share Analysis

The spinal devices and biologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spinal devices and biologics market.

Key players operating in the spinal devices and biologics market include:

  • Exactech, Inc., (U.S.)
  • Zimmer Biomet (U.S.)
  • Medtronic (Ireland)
  • Globus Medical (U.S.)
  • Integra LifeSciences (U.S.)
  • NuVasive, Inc., (U.S.)
  • Stryker (U.S.)
  • Orthofix US LLC (U.S.)
  • Wright Medical Group N.V. (U.S.)
  • Smith+Nephew (U.K.)
  • ZAVATION (U.S.)


SKU-

Why Choose Us


Frequently Asked Questions

The spinal devices and biologics market value was USD 2.64 billion in 2021.